Remedios Rios Barrera

Institutions of which they are part

Senior researcher
Cardiovascular Diseases

Vall Hebron Institut de Recerca

Remedios Rios Barrera

Institutions of which they are part

Senior researcher
Cardiovascular Diseases

Vall Hebron Institut de Recerca

Projects

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio.

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Remedios Rios Barrera, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Instituto de Salud Carlos III
Funding: 127500
Reference: PI23/00260
Duration: 01/01/2024 - 31/12/2026

Related news

Team from the VHIR's Cardiovascular Diseases group that participated in the study

Diesel particulates increase serious arrhythmias risk; cerium could protect the heart

A study led by the Vall d'Hebron Research Institute (VHIR) demonstrates the causal role of air pollution in ventricular arrhythmias and identifies a possible therapeutic strategy based on antioxidants.

Four VHIR professionals receive funding from PERIS to intensify their research activity

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.